Diurnal Interim Loss Widens On Cost Rise As Prepares For First Revenue
12th Mar 2018 10:18
LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Monday its interim loss widened amid a rise in research and administrative expenses, as it prepares to its Read More